Association of serum uric acid and C-reactive protein levels in prediction of pre-eclampsia

Pawanpreet Kaur, Deepak A. Desai, Aartee Taraiya, Apexa Patel


Background: Hypertensive disorders during pregnancy increase maternal and infant risk. The greatest impact is associated with the pregnancy-specific syndrome, preeclampsia, a consistently clinically worsening situation. PE is a complication of pregnancy, constituting a major cause of maternal and foetal morbidity, and mortality

Hyperuricemia and increased CRP level, in pre-eclamptic patients need to be confirmed, in a designed strategy, in which uric acid and CRP level are  measured before the development of preeclampsia, or early in pregnancy, in order to identify and monitor the patients, “at risk of preeclampsia”, and thus  provide the best prenatal care for these women and their babies.

Methods: The study was done in Dhiraj Hospital in Obstetrics and Gynecology Department. The study duration was 1 year. It is a prospective type of study comprising of patients, who were attending ANC clinic and were booked cases at Dhiraj hospital. Serum uric acid and C-reactive protein were estimated along with other routine investigations for all patients attending ANC clinic. All the subjects were divided into two groups: (i) Group-1 (Study Group): Fifty diagnosed pre-eclamptic patients in third trimester of pregnancy (37-40 weeks) whose serum uric acid and CRP levels were already raised during her antenatal visits in second trimester, (ii) Group-2 (Control Group): fifty two normal pregnant women of comparable gestational age.

Results: The mean values of serum uric acid and CRP levels remain higher in study group than that of control group. This difference is statistically significant (p= 0.02).

Conclusions: All the patients in study group whose measurement of uric acid and CRP levels were high, developed pre-eclampsia. So it can be fairly concluded, that the observed elevations in serum uric acid level or CRP level or both, preceded the development of pre-eclampsia.


Pre-eclampsia, Serum uric acid levels, Serum CRP levels

Full Text:



Parks DA, Williams TK, Beckman JS. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol. 1988;254:G768-74.

Tan S, Gelman S, Wheat JK, Parks DA. Circulating xanthine oxidase in human ischemia reperfusion.South Med J. 1995;88:479-82.

Lazzarino G, Raatikainen P, Nuutinen M, Nissinen J, Tavazzi B, Di Pierro D, et al. Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery.Circulation. 1994;90:291-7.

White CR, Darley-Usmar V, Berrington WR, Mcadams M, Gore JZ, Thompson JA, et al. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci U S A. 1996;93:8745.

Powers RW, Bodnar LM, Ness RB, Cooper KM, Gallaher MJ, Frank MP, et al. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol. 2006;194:160.

Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183-90.

Reilly RD, Russell PT. Neurohistochemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta and umbilical cord. Anat Rec. 1977;188:277-86.

Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13:2888-97.

Kang DH, Finch J, Nakagawa T, Karumanchi SA, Kanellis J. Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link. J Hypertens. 2004;22:229-35.

Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67:1739-42.

Martin AC, Brown MA. Could uric acid have a pathogenic role in preeclampsia? Nat Rev Nephrol. 2010;6:744-8.

Elias S, Annas GJ. Generic consent for genetic screening. N Engl J Med. 1994;330:1611.

Saugstad OD. Hypoxantine as measurement of hypoxia. Pediatr Res. 1975;9:158-61.

Ingec M, Borekci B, Kadanali S. Elevated plasma homocysteine Concentrations in severe preeclampsia and eclampsia. Tohoku J Exp Med. 2005;206:225-31.

DiNapoli M, Elkind MSV, Godoy DA, Singh P, Papa F, Wagner AP. Role of C-reactive protein in Cerebrovascular Disease. Expert Rev Cardiovasc Ther. 2011;9(12):1565-84.

Ridker PM. C-reactive protein: A Simple Test to Help Predict Risk of Heart Attact and Stroke. Circulation. 2003;108:81-5.

Kolder VEB, Gallagher J, Parsons MT: Court-ordered obstetrical interventions. N Engl J Med. 1987;316:1192.

Nelson LJ, Milliken N. Compelled medical treatment of pregnant women. JAMA. 1988;259:1060.

Notzon FC, Placek PJ, Taffel SM. Comparisons of national caesarean-section rates. N Engl J Med. 1987;316:386.